M. S. O'Mahony

3.3k total citations · 1 hit paper
30 papers, 2.3k citations indexed

About

M. S. O'Mahony is a scholar working on Geriatrics and Gerontology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. S. O'Mahony has authored 30 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Geriatrics and Gerontology, 8 papers in Physiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. S. O'Mahony's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Frailty in Older Adults (4 papers). M. S. O'Mahony is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Frailty in Older Adults (4 papers). M. S. O'Mahony collaborates with scholars based in United Kingdom, Australia and Canada. M. S. O'Mahony's co-authors include Ken Woodhouse, Ruth E. Hubbard, Eleri Davies, Philip A. Routledge, Brian L. Calver, K.W. Woodhouse, Mark Kinirons, George M. Savva, Preeti Gupta and Harpreet Wasan and has published in prestigious journals such as The Lancet, Journal of the American Geriatrics Society and Pharmacology & Therapeutics.

In The Last Decade

M. S. O'Mahony

29 papers receiving 2.2k citations

Hit Papers

Adverse drug reactions in special populations – the elderly 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. S. O'Mahony United Kingdom 17 1.1k 524 523 287 283 30 2.3k
Fei‐Yuan Hsiao Taiwan 31 773 0.7× 461 0.9× 414 0.8× 309 1.1× 441 1.6× 205 3.0k
Ken Woodhouse United Kingdom 19 734 0.7× 482 0.9× 341 0.7× 123 0.4× 199 0.7× 54 1.9k
Marilisa Franceschi Italy 35 711 0.6× 661 1.3× 298 0.6× 139 0.5× 337 1.2× 94 3.3k
Susanna M. Wallerstedt Sweden 28 524 0.5× 241 0.5× 264 0.5× 174 0.6× 360 1.3× 128 3.1k
Annie Fourrier‐Réglat France 31 650 0.6× 248 0.5× 366 0.7× 249 0.9× 504 1.8× 125 3.7k
Emily Hajjar United States 16 2.4k 2.2× 180 0.3× 1.2k 2.3× 106 0.4× 682 2.4× 29 3.5k
Rob J. van Marum Netherlands 29 824 0.7× 255 0.5× 449 0.9× 38 0.1× 289 1.0× 132 2.8k
Mikkel Christensen Denmark 39 514 0.5× 915 1.7× 251 0.5× 270 0.9× 287 1.0× 163 5.6k
Frank R. Ernst United States 18 494 0.4× 101 0.2× 220 0.4× 132 0.5× 256 0.9× 55 2.3k
Sylvie Perreault Canada 36 615 0.6× 423 0.8× 698 1.3× 156 0.5× 937 3.3× 153 3.9k

Countries citing papers authored by M. S. O'Mahony

Since Specialization
Citations

This map shows the geographic impact of M. S. O'Mahony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. O'Mahony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. O'Mahony more than expected).

Fields of papers citing papers by M. S. O'Mahony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. O'Mahony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. O'Mahony. The network helps show where M. S. O'Mahony may publish in the future.

Co-authorship network of co-authors of M. S. O'Mahony

This figure shows the co-authorship network connecting the top 25 collaborators of M. S. O'Mahony. A scholar is included among the top collaborators of M. S. O'Mahony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. S. O'Mahony. M. S. O'Mahony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O'Mahony, M. S., et al.. (2020). Deprescribing in older people. British Journal of Hospital Medicine. 81(1). 1–9. 4 indexed citations
2.
Eeles, Eamonn, Nancye M. Peel, Susan V. White, et al.. (2013). Frailty and illness severity in relation to delirium in older inpatients. Queensland's institutional digital repository (The University of Queensland). 2 indexed citations
3.
Ahmed, Tamjeed, John Steward, & M. S. O'Mahony. (2012). Dyspnoea and mortality in older people in the community: a 10-year follow-up. Age and Ageing. 41(4). 545–549. 26 indexed citations
4.
Seymour, Michel, Lindsay C Thompson, Harpreet Wasan, et al.. (2011). Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. The Lancet. 377(9779). 1749–1759. 270 indexed citations
5.
Eeles, Eamonn, Ruth E. Hubbard, Susan V. White, et al.. (2010). Hospital use, institutionalisation and mortality associated with delirium. Age and Ageing. 39(4). 470–475. 84 indexed citations
6.
Hubbard, Ruth E., M. S. O'Mahony, George M. Savva, Brian L. Calver, & Ken Woodhouse. (2009). Inflammation and frailty measures in older people. Journal of Cellular and Molecular Medicine. 13(9b). 3103–3109. 303 indexed citations
7.
Hubbard, Ruth E., M. S. O'Mahony, Brian L. Calver, & Ken Woodhouse. (2008). Plasma esterases and inflammation in ageing and frailty. European Journal of Clinical Pharmacology. 64(9). 895–900. 107 indexed citations
8.
Gupta, Preeti & M. S. O'Mahony. (2008). Potential Adverse Effects of Bronchodilators in the Treatment of Airways Obstruction in Older People. Drugs & Aging. 25(5). 415–443. 69 indexed citations
9.
Hubbard, Ruth E., M. S. O'Mahony, Brian L. Calver, & Ken Woodhouse. (2008). Nutrition, Inflammation, and Leptin Levels in Aging and Frailty. Journal of the American Geriatrics Society. 56(2). 279–284. 87 indexed citations
10.
Ahmad, Sartaj & M. S. O'Mahony. (2005). Where older people die: a retrospective population-based study. QJM. 98(12). 865–870. 38 indexed citations
11.
Wani, Mushtaq Ahmad, et al.. (2005). Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age. Age and Ageing. 34(4). 395–398. 25 indexed citations
12.
Kinirons, Mark & M. S. O'Mahony. (2004). Drug metabolism and ageing. British Journal of Clinical Pharmacology. 57(5). 540–544. 162 indexed citations
13.
O'Mahony, M. S., et al.. (2003). European Reference Values for Doppler Indices of Left Ventricular Diastolic Filling. European Journal of Heart Failure. 6(4). 433–438. 5 indexed citations
14.
Routledge, Philip A., M. S. O'Mahony, & Ken Woodhouse. (2003). Adverse drug reactions in elderly patients. British Journal of Clinical Pharmacology. 57(2). 121–126. 341 indexed citations
15.
O'Mahony, M. S., et al.. (2003). Diastolic heart failure in older people. Age and Ageing. 32(5). 519–524. 19 indexed citations
16.
Bandyopadhyay, Soham, M. S. O'Mahony, & Manivannan Pathy. (2002). Smoking habits and attitudes of age concern volunteers. Archives of Gerontology and Geriatrics. 35(1). 21–25. 2 indexed citations
17.
O'Mahony, M. S., et al.. (2000). Plasma esterase activities in young and old patients undergoing open inguinal hernia repair. Archives of Gerontology and Geriatrics. 31(3). 193–198. 8 indexed citations
18.
Johansen, Antony, et al.. (1997). Reliability of parathyroid hormone measurements in the period immediately following hip fracture. Age and Ageing. 26(3). 175–178. 9 indexed citations
19.
O'Mahony, M. S. & Ken Woodhouse. (1994). Age, environmental factors and drug metabolism. Pharmacology & Therapeutics. 61(1-2). 279–287. 32 indexed citations
20.
Schmucker, Douglas L., M. S. O'Mahony, & Elliot S. Vesell. (1994). Women in Clinical Drug Trials. Clinical Pharmacokinetics. 27(6). 411–417. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026